I would love to see the forecast model that justifies the development spend in Afinitor. A small share of RCC and then two rare tumor types. Start celebrating when SEGA breaks 75 scripts. A breast indication is the big hope or better yet wet dream
I think there's considerably more profit potential in pNuts, as they are sold at all sports venues and many concert venues. A natural food low in sugar and high in protein.